ERBB2 and breast carcinoma: Denkert Denkert C C Seither Seither F F Schneeweiss Schneeweiss A A Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials Lancet Oncol Lancet Oncol 2021 2021 22 22 8 8 1151 1151 1161 1161 10.1016/S1470-2045(21)00301-6 10.1016/S1470-2045(21)00301-6 supplied-pmid 34252375?